Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats
David E. Moorman, Morgan H. James, Elisabeth A. Kilroy, et al.
Brain Research (2016) Vol. 1654, pp. 34-42
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 108
Recent Perspectives on Sex Differences in Compulsion-Like and Binge Alcohol Drinking
Anna K. Radke, Elizabeth A. Sneddon, Raizel M. Frasier, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3788-3788
Open Access | Times Cited: 85
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
The role of orexin-1 receptor signaling in demand for the opioid fentanyl
Jennifer E. Fragale, Caroline B. Pantazis, Morgan H. James, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 10, pp. 1690-1697
Open Access | Times Cited: 68
Intermittent self‐administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system
Jennifer E. Fragale, Morgan H. James, Gary Aston‐Jones
Addiction Biology (2020) Vol. 26, Iss. 3
Open Access | Times Cited: 65
Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin‐1 receptor antagonist in rats
Morgan H. James, Hannah E. Bowrey, Colin M. Stopper, et al.
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2602-2612
Open Access | Times Cited: 64
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Orexin/Hypocretin System: Role in Food and Drug Overconsumption
Jessica R. Barson, Sarah F. Leibowitz
International review of neurobiology (2017), pp. 199-237
Open Access | Times Cited: 56
Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation
Natalie Nevárez, Luı́s de Lecea
F1000Research (2018) Vol. 7, pp. 1421-1421
Open Access | Times Cited: 56
Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil
Aida Mohammadkhani, Jennifer E. Fragale, Caroline B. Pantazis, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 49, pp. 9831-9840
Open Access | Times Cited: 52
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Erin J. Campbell, Nathan J. Marchant, Andrew J. Lawrence
Brain Research (2018) Vol. 1731, pp. 145902-145902
Closed Access | Times Cited: 50
Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder
Robert Suchting, Jin H. Yoon, Guadalupe G. San Miguel, et al.
Brain Research (2019) Vol. 1731, pp. 146359-146359
Closed Access | Times Cited: 45
The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand
Caroline B. Pantazis, Morgan H. James, Brandon S. Bentzley, et al.
Addiction Biology (2019) Vol. 25, Iss. 4
Open Access | Times Cited: 44
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report
Erin J. Campbell, Yvonne Bonomo, Lisa Collins, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 5
Effects of daridorexant on rest/wake activity patterns and drinking in adult rats exposed to chronic ethanol vapor in adolescence
Leslie R. Amodeo, Derek N. Wills, Jason Benedict, et al.
Alcohol (2025)
Open Access
Genetic associations between orexin genes and phenotypes related to behavioral regulation in humans, including substance use
Fazil Alıev, David De Sa Nogueira, Gary Aston‐Jones, et al.
Molecular Psychiatry (2025)
Open Access
Orexin receptors: possible therapeutic targets for psychiatric disorders
Shigeyuki Chaki
Psychopharmacology (2025)
Closed Access
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil
Aida Mohammadkhani, Morgan H. James, Caroline B. Pantazis, et al.
Brain Research (2019) Vol. 1731, pp. 146461-146461
Open Access | Times Cited: 41
The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System
Jennifer E. Fragale, Morgan H. James, Jorge A. Avila, et al.
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 117-127
Open Access | Times Cited: 29
Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Glenn Pascasio, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 7, pp. 647-660
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top